In mouse xenograft models of breast cancer, we have previously shown that systemic treatment with the PAD inhibitor, Cl-Amidine, resulted in increased tumoral basement membrane integrity compared to tumors from mice treated with vehicle alone [14, 47]. Here, PADI4 is linked to breast cancer.